MOTS - モ―タスGIホ―ルディングス （Motus GI Holdings Inc.） モ―タスGIホ―ルディングスMOTSのチャート
MOTSの企業情報
| symbol | MOTS |
|---|---|
| 会社名 | Motus GI Holdings Inc （モ―タスGIホ―ルディングス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | 先端医療機器_テクノロジ― 医療関連（Health Care） |
| 概要 | 事業概要 Motus GI Holdings Inc. is a medical technology company that operates along with its subsidiaries Motus Ltd. and Motus Inc. The Company is developing Pure-Vu system that integrates with existing colonoscopes to cleanse poorly prepped colons during the colonoscopy procedure. The Pure-Vu system uses a precise mixture of water and air to loosen debris from the colon mucosa while simultaneously evacuating the bowel contents clearing the way for the endoscopist to perform a high quality examination even when the patient is not fully clean prior to their procedure. The Pure-Vu System also helps in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon This device fits standard colonoscopes allowing the physician to clean poorly-prepped colons in a safe and effective manner to gain clear visualization of the colon mucosa. モ―タスGIホ―ルディングスはイスラエルの医療テクノロジ―企業。米国において内視鏡検査ソリュ―ション事業に従事する。米国食品医薬品局(FDA)承認済みのPURE-VUシステムは、内視鏡検査時の腸内洗浄および腸粘膜をより鮮明に視覚化し、安全かつ高い費用対効果で医療現場へ供給する。本社所在地はティラットカ―メル。 motus gi holdings, inc. (nasdaq: mots) is a medical technology company based in the u.s., with subsidiaries in the u.s. and israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. the company is focused on the development and commercialization of the pure-vu® system, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. the pure-vu® system is a 510(k) u.s. food and drug administration cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. the device integrates with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. the pure-vu® system has received ce mark approval in europe. |
| 本社所在地 | 1301 East Broward Boulevard 3rd Floor Ft. Lauderdale FL 33301 USA |
| 代表者氏名 | David P. Hochman David P. Hochman |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 786-459-1831 |
| 設立年月日 | 42614 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | 2018年 |
| 従業員数 | 359人 |
| url | www.motusgi.com |
| nasdaq_url | https://www.nasdaq.com/symbol/mots |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -16.24100 |
| 終値（lastsale） | 4.74 |
| 時価総額（marketcap） | 74315222.58 |
| 時価総額 | 時価総額（百万ドル） 69.92529 |
| 売上高 | 売上高（百万ドル） 0.02900 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 54.98029 |
| 当期純利益 | 当期純利益（百万ドル） -18.84700 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Motus GI Holdings Inc revenues increased from $0K to $38K. Net loss increased 84% to $11.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects General and administrative - Balancing v increase of 49% to $2.9M (expense) Research and development expenses net - increase of 47% to $2.5M (expense). |
MOTSのテクニカル分析
MOTSのニュース
Motus GI Holdings promotes Ravit Ram to CFO 2023/06/05 21:04:25 Seeking Alpha
Motus GI Holdings (MOTS) has announced the promotion of its current Vice President of Global Operation and Finance, Ravit Ram, as the new CFO, effective immediately.Ms
BE Stock Price Prediction: Can Bloom Energy Rally More Than 45% From Here? 2023/05/19 13:44:55 InvestorPlace
Bloom Energy (NYSE: BE ) stock could see a major rally as one analyst set a bullish price prediction for the shares. JPMorgan analyst Mark Strouse is behind this news as he assigned a new price target of $20 per share to BE stock. Funnily enough, that’s a $2 drop from its prior price target but still represents a roughly 45% upside. Even if it’s below the analysts’ consensus price target of $28.19 per share. With that updated price prediction comes an upgrade for BE stock. Strouse bumped shares up from a “neutral” rating to an “overweight” rating. For comparison, the analysts’ consensus rating is “moderate-buy” based on 15 opinions. What’s Behind That BE Stock Upgrade? Here’s what the JPMorgan analyst said about BE stock in a note to clients obtained by CNBC . “We believe the recent pullback … is overdone and that investors can take advantage of the volatility to add to positions in a stock that we believe will be a long-term beneficiary of the energy transition.” Traders will also want to keep an eye on BE stock next week.
Why Is Motus GI (MOTS) Stock Down Today? 2023/05/19 13:07:52 InvestorPlace
Motus GI (NASDAQ: MOTS ) stock is slipping on Friday after the medical technology company announced a private placement. This has Motus GI offering 4,142,012 shares of MOTS stock for $0.845 each. These shares also each come with a single warrant to purchase an additional share of the company’s stock. The warrants are exercisable for 72 cents per share. That private placement was revealed yesterday and is set to close today. In total, Motus GI expects to raise some $3.5 million from the offering. It will use these funds for working capital and general corporate purposes. MOTS Stock Movement Motus GI originally announced the private placement yesterday, which resulted in shares of MOTS stock falling almost 18% during normal trading hours. That came alongside some 776,000 shares changing hands. For comparison, the company’s daily average trading volume is closer to 303,000 shares. It doesn’t look like shares of MOTS stock are done falling just yet as they continue to give up ground on Friday morning.
Motus GI drops 19% on $3.5M private placement 2023/05/18 12:22:26 Seeking Alpha
Medical technology company, Motus GI (MOTS) announces agreements for the issuance and sale of an aggregate of 4.14M shares and warrants to purchase up to an aggregate of 4.14M at a…
Motus GI Holdings Prices 4.14M Share Offering at $0.845/sh 2023/05/18 12:05:02 Investing.com
https://www.investing.com/news/assorted/motus-gi-holdings-prices-414m-share-offering-at-0845sh-432SI-3085600
Ladenburg Thalmann Downgrades Motus GI Holdings to Neutral 2023/01/23 14:42:09 Investing.com
https://www.investing.com/news/pro/ladenburg-thalmann-downgrades-motus-gi-holdings-to-neutral-432SI-2985986
Mind-boggling stocks: MultiMetaVerse Holdings Limited (NASDAQ:MMV), Motus GI Holdings, Inc. (NASDAQ:MOTS) 2023/01/10 23:56:22 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Mind-boggling stocks: MultiMetaVerse Holdings Limited (NASDAQ:MMV), Motus GI Holdings, Inc. (NASDAQ:MOTS) appeared first on Stocks Equity .
Motus GI Holdings Inc.’s (NASDAQ: MOTS) Stock Could Appreciate By -986.96% 2023/01/10 20:00:00 Marketing Sentinel
In the latest trading session,, 1.08 million Motus GI Holdings Inc. (NASDAQ:MOTS) shares changed hands as the company’s beta touched 1.82. With the company’s most recent per share price at $0.92 changed hands at -$0.08 or -8.05% at last look, the market valuation stands at $4.38M. MOTS’s current price is a discount, trading about -1313.04% … Motus GI Holdings Inc.’s (NASDAQ: MOTS) Stock Could Appreciate By -986.96% Read More »
Motus GI Holdings Inc. (NASDAQ:MOTS) stock: Is this a flash in the pan today? 2023/01/10 17:08:00 US Post News
Motus GI Holdings Inc. (MOTS)’s stock has witnessed a price declined of -8.36% from the previous close with its current price standing at $0.92. Its current price is -92.95% under its 52-week high of $13.00 and 34.76% more than its 52-week low of $0.68. Based on the past 30-day period, the stock price is -31.19% […]
MOTS stock gains on plans for strategic alternatives (NASDAQ:MOTS) 2023/01/10 13:53:47 Seeking Alpha
Motus GI Holdings (MOTS) announced Tuesday it started a process to evaluate multiple strategic and financing alternatives. Read the full story here.
90 Biggest Movers From Yesterday 2022/05/10 09:11:32 Benzinga
Gainers Hemisphere Media Group, Inc (NASDAQ: HMTV ) shares climbed 78.8% to close at $6.74 on Monday after the company announced it entered into a definitive agreement to be acquired for $7.00 per share in cash by a subsidiary of Gato Investments, a portfolio investment of Searchlight Capital Partners. Blue Water Vaccines, Inc. (NASDAQ: BWV ) gained 44.2% to close at $5.42 on heavy volume. Points.com Inc. (NASDAQ: PCOM ) rose 43.3% to close at $24.46. Plusgrade announced plans to acquire Points for $25 per share in cash. ServiceSource International, Inc. (NASDAQ: SREV ) gained 41.7% to settle at $1.4450 after the company announced it will be acquired by Concentrix Corporation in an all-cash merger. LogicBio Therapeutics, Inc. (NASDAQ: LOGC ) gained 34.4% to close at $0.6673 after the company announced the FDA lifted the clinical hold on its LB-001 Investigational New Drug Application, allowing patient enrollment to resume in the Phase 1/2 SUNRISE trial for pediatric patients with methylmalonic acidemia.
Motus GI Announces Upcoming Presentation of Topline Data from the EU Study of the Pure-Vu System at Digestive Disease Week 2022 2022/05/02 12:00:00 Wallstreet:Online
FORT LAUDERDALE, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today a poster featuring topline data from the EU study of the
Motus GI Completes Enrollment in the European Union Feasibility Study of the Pure-Vu System as a New Method for Bowel Cleansing in Patients with a History of Poor Bowel Preparation 2022/04/21 12:00:00 Wallstreet:Online
Topline data expected to be presented at a scientific conference in May 2022 Independent data shows ~5.4M outpatient colonoscopies are performed in EU annually1 New study data expected to further aid in commercial adoption FORT LAUDERDALE, Fla., April 21, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology